In-vitro study for sensitivity to Cephalexin in samples from community acquired skin and soft tissue infections
Not Applicable
Completed
- Conditions
- Health Condition 1: L029- Cutaneous abscess, furuncle and carbuncle, unspecified
- Registration Number
- CTRI/2020/01/022605
- Lead Sponsor
- CTQuest LLP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
Gram positive cultures from community acquired/associated skin and soft tissue infection. A skin and soft tissue infection will be considered community-associated/acquired if the infection arose outside the healthcare setting and there is no history of surgery, hospitalization, catheterization, any other invasive procedure in the previous year, antibiotic usage in the previous two months or MRSA isolation in the past.
Exclusion Criteria
samples from-surgical wounds, post instrumentation, diabetic foot infections, human or animal bite infections or from patients with history of hospital stay in last 3 weeks will be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assess the sensitivity to Cephalexin in bacterial community acquired acute skin and soft tissue infectionsTimepoint: Day 1- At time of sample collection
- Secondary Outcome Measures
Name Time Method Identify the bacterial profile of community acquired acute skin and soft tissue infectionsTimepoint: Day 1 at time of sample collection